PDL BioPharma Inc. (PDLI) Jumped 6.38% or 0.16 To Price $2.58 On Monday


PDL BioPharma Inc. (PDLI) jumped 6.38% or 0.16 to $2.58. It is approximately 1.72 million shares traded, which is 118.75% compare to the average total volume 1.45 million. The market cap of PDLI is $375.86 million. The year to date change is -8.95%. The 52 week price range is from $2.25 to $3.55. Price of PDLI have changed 6.58% during last week. It have changed 4.29% over last month, 0.41% over last 3 months, -17.91% over last 6 months and -25.69% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PDLI is 2.44. It is -5.43% below current price. The 200-day Moving Averages for PDLI is 2.68. It is 3.88% above current price. The 52-week High is 3.55. It is 37.60% from the current price. The 52-week Low is 2.25. It is -12.79% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of PDLI is 16.7 on 2018-08-31. Short % to float is 13.51%. There are some statistics of PDLI. It is has market cap $375.86 million. The share outstanding is 145.40 million. The average volume is 1.45 million. The revenue is 62.75M. It has 516.49M cash and 240.64M in debt. The gross profit is 57.18M. The percent of top 15 Institution holding is 80.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PDLI is -8.73%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PDLI is -5.94%.


Tags:

Share this post